of donor origin are detectable, or as mixed chimeras if a mixture of both donor and recipient origin cells are found after BMT. With the use of increasingly sensitive techFifty-eight samples of bone marrow (31), whole peripheral blood (8) and separated fractions of circulating niques, mixed chimerism is frequently observed after allogeneic BMT. [2] [3] [4] [5] [6] Several factors related to transplant promononuclear (11) and polymorphonuclear (8) cells from 18 male patients, transplanted for hematological discedures (type of donor, conditioning regimens, T cell depletion, graft-versus-host disease (GVHD) prophylaxis) eases from related (14) or unrelated (4) female donors were analyzed for chimerism at subsequent intervals and patient features (underlying disease, age) have been shown to be associated with an increase in mixed chimer-(range, 1-72 months) following bone marrow transplantation, by means of PCR amplification of the Y-chromism (MC) after sibling BMT. [7][8][9][10][11][12] Residual male cells were shown to persist in patients grafted with T cell non-depleted osome-specific DYS14 sequence, revealed by a radiolabelled hybridization probe (dot blot technique, 0.01% marrow from an HLA-identical female donor, when clinical and hematological conditions indicated a complete sensitivity). Detection of male cells was positive in all but two of 52 samples collected within the third year engraftment and the absence of recurrent disease. 4, 5, 13 The need to extend the analysis of MC following BMT to a after transplantation and negative in six samples collected from three patients after the third year. In the larger series of prospectively evaluated patients with adequate follow-up, prompted us to investigate the persistfirst year after transplantation, mixed chimerism was found in all patients, apparently with no correlation ence of residual recipient cells in a series of pediatric male patients grafted from a female donor. Our findings on seriwith graft-versus-host disease. Comparable results were found in fractions of mononuclear and polymorphoally collected samples from patients in long-term continuous complete remission (CCR) establish the kinetics of the nuclear cells, when analyzed separately. The persistence of very low levels of recipient cells in patients in conresidual recipient cells, with no apparent correlation with post-transplant events. tinuous complete remission until the third year after transplantation, suggests the persistence of normal host hemopoiesis for a long period of time after the so-called myeloablative regimen. The progressive negativization, Patients and methods occurring in our patients between the second and the fourth year after transplantation, could signify the disPatients appearance of residual host hemopoiesis or its decrease to below the detection level of this highly sensitive Eighteen male patients who received a marrow graft from familial (14) or unrelated (four) female donor at the Pedimethod. Keywords: chimerism; bone marrow transplantation; dot atric Department of the University of Milan or Turin between 1990 and 1995, were analyzed for chimerism after blot-PCR transplantation. Sixteen of these 18 patients were transplanted for hematological diseases: 11 acute lymphoblastic (ALL) and two non-lymphoblastic leukemia (ANLL), one An increasing number of methods have been used to anajuvenile (JCML) and one Philadelphia-positive chronic lyze chimerism after bone marrow transplantation (BMT) myelogenous leukemia (CML), one refractory anemia with to evaluate engraftment or rejection, to detect minimal excess of blasts (RAEB-t), one Langherans histiocytosis residual disease or recurrence of leukemia and to clarify and one thalassemia. Conditioning regimens varied accordthe clinical significance of the presence of mixtures of heming to the underlying diseases and included total body opoietic cells of donor and recipient origins. ents before transplant and from the recipient from 1 to 24 tains 6 × standard saline citrate (SSC), 2 × Denhardt's solution, 0.1% SDS and 100 g/ml salmon sperm DNA. In months post-transplant. Sex-mismatched pairs were selected for this study only when adequate follow-up (from 11 the prehybridized solution 1 × 10 6 c.p.m./ml of labelled probe was added. After 16 h of hybridization, the memto 72 months after BMT) in CCR was available for the patient or when death occurred in CR as assessed by stanbranes were washed for 45 min in 2 × SSC and 0.05% SDS at room temperature, followed by a second 20-min washing dard criteria. After the first year, peripheral blood (PB) samples were collected prospectively.
ents before transplant and from the recipient from 1 to 24 tains 6 × standard saline citrate (SSC), 2 × Denhardt's solution, 0.1% SDS and 100 g/ml salmon sperm DNA. In months post-transplant. Sex-mismatched pairs were selected for this study only when adequate follow-up (from 11 the prehybridized solution 1 × 10 6 c.p.m./ml of labelled probe was added. After 16 h of hybridization, the memto 72 months after BMT) in CCR was available for the patient or when death occurred in CR as assessed by stanbranes were washed for 45 min in 2 × SSC and 0.05% SDS at room temperature, followed by a second 20-min washing dard criteria. After the first year, peripheral blood (PB) samples were collected prospectively.
in 6 × SSC and 0.1% SDS at 42°C and exposed to XAR-5 film (Eastman Kodak, Rochester, NY, USA) with an intensifying screen at Ϫ80°C for 3-6 h.
Sample collection and DNA extraction
Mononuclear cells (MNC), either from BM or PB samples were obtained after Ficoll-Hypaque density gradient centriResults fugation. After centrifugation of the PB samples, the pellets were resuspended in a solution of dextran sulfate to obtain
To assess the sensitivity of the PCR amplification of the Y chromosome-specific DYS14 sequence, DNA from a male a PMN cell fraction. After this separation, the PMN fraction consisted of more than 80% of PMN cells, as assessed by individual was serially diluted with DNA of a female individual. As shown in Figure 1 , dot blot analysis of the PCR morphological criteria on Wright-Giemsa-stained cytospins. Genomic DNA from either fresh PB or frozen BM products, showed that under these conditions the male DNA can be detected up to 10
Ϫ4
-10 Ϫ5 dilution, indicating the mononuclear cells was isolated by sodium dodecyl sulfate (SDS)-proteinase K treatment and phenol/chloroform high sensitivity of this method. YNZ-22, 16 MCT-118 17 was used in the initial screening summarized in Table 1 . BM MNC cells were found to be positive for residual male cells for a time period ranging process to identify at least one polymorphic marker between a given donor-recipient pair. Once informative from 1 to 24 months. All the patients were in continuous complete remission of their disease at the time of analysis markers were defined, PCR amplification of post-transplant BM and PB samples was performed to estimate the degree based on clinical and hematological parameters, as well as for the assessment of complete chimeras by PCR amplifiof chimerism. As in previous reports, PCR amplification of minisatellite sequences allowed the detection of residual cation of minisatellite sequences. To address the question of the long-term kinetics of the residual male cell popurecipient cells in the range between 0.1 and 1% (data not shown). 18 PCR amplification of the Y chromosome-specific lations, we considered blood samples collected 1 month to 6 years after BMT from 11 of the male patients beyond the sequence DYS14 was performed according to the methods previously described using primers Y1 5Ј CTAGACCGCAfirst year after BMT (Table 1) . Residual male cells can be detected either in the MNC and PMN fractions for a period GAGGCGCCAT 3Ј and Y2 5Ј TAGTACCCACGC-CTGCTCCGG 3Ј, 3 located respectively at positions 693 of time ranging from 18 to 34 months. All the samples analyzed after the third year from BMT were negative, as and 911, of the DYS14 sequence. 4, 19 The PCR amplification of DYS14 yields a PCR product of 239 bp in male cells.
shown for representative cases (Nos 1, 3, 6) in Figure 2 . Thus it appears that for at least 3 years after BMT, residual The PCR was carried out with 1 g DNA for each sample, dissolved in a 100 l reaction containing 1 ϫ PCR buffer, hemopoietic cells can remain in the host, despite a full donor engraftment. 1 mm MgCl 2 , 0.2 mm of each of the four deoxynucleotide triphosphates (DNTP), 0.3 m of each of the primers and 2.5 U of Thermus aquaticus (Taq) DNA polymerase (Boehringer Mannheim, Mannheim, Germany). Thirty Discussion cycles of amplification were performed consisting of 2 min at 94°C, 3 min at 55°C and 3 min at 72°C, followed by a In this study, residual male cells were identified by means of PCR amplification of the Y chromosome-specific final extension step of 10 min at 72°C. After PCR, 10 l aliquots of all products of amplification were electrophor-DYS14 sequence in BM and PB samples collected in 18 male children recipients of unmodified marrow graft from esed in Tris-borate buffer on 2% agarose gels stained with ethidium bromide. A 21 base oligonucleotide, 5Ј-GCAGCTCGGCTTCGATGTGAC-3Ј located at position 839, which corresponds to a sequence within the target region, was used as a hybridization probe. After PCR, 10 l aliquots of amplified products were dotted onto nylon mem- branes (Genescreen Plus; New England Nuclear, Boston, The probe was labelled for 45 min at 37°C using ␥- bridized and hybridized at 42°C using a solution which conLong-term mixed chimerism after BMT S Mangioni et al 971 BM ϭ bone marrow; PB ϭ peripheral blood; WBC ϭ white blood cells; MNC ϭ mononuclear cells; PMN ϭ polymorphonuclear cells; ANLL ϭ acute non-lymphoblastic leukemia; JCML ϭ juvenile chronic myelogenous leukemia; ALL ϭ acute lymphoblastic leukemia; Thalass ϭ thalassemia; RAEBt ϭ refractory anemia with excess of blasts; CCR ϭ continuous complete remission; NE ϭ not evaluable; UK ϭ unknown.
female donors. Residual host cells were found by this either the residual host hemopoiesis represents a transient event, or that it persists longer but below the detection limit highly sensitive technique, even in the presence of full engraftment as assessed by PCR amplification of minisaof the method used. As carefully addressed by Petit et al, 13 residual cells are likely to be of hemopoietic origin. The tellite sequences. These findings confirm and further extend previous observations on the persistence of recipient cells levels of detection were comparable in both fractions of MNC and PMN cells isolated from eight of the 18 analyzed post-BMT. [3] [4] [5] [6] 13, 20, 21 As expected, male cells were consistently found in the 18 patients evaluated within the first year, cases ( Figure 2 ). Although unlikely, contamination by nonhemopoietic cells cannot be ruled out; stromal cells could indicating persistence of residual host hemopoietic cells during the early phase, which had not been completely not be responsible for male cell detection, at least in PB samples. Detection of donor leukocytes in immunocompetdestroyed by the conditioning regimens. Ten of the 12 fully engrafted evaluable patients in CCR were analyzed beyond ent trauma patients receiving non-irradiated RBC has recently been reported; the possible establishment of longthe first year. The progressive disappearance of recipient's hemopoietic cells occurs between the second and the fourth term chimerism was described 18 months after transfusion. 22 Contaminations by transfused cells cannot be year after transplantation since in those patients who switched to Y chromosome negativity, the last positive excluded in our polytransfused patients, even though all blood products are routinely irradiated before infusion samples were collected between 12 and 24 months after transplantation and the earliest negative samples were colthrough a high-efficiency leukocyte removal filter. No correlations were found with the underlying disease, the type lected between 21 and 72 months ( Table 1 ). The progressive negativization occurring in our patients between the of transplant, the conditioning regimen and the development of GVHD, due to the limited number of patients. The second and the fourth year post-BMT could mean that in disease remission (see Table 1 ). In the first lane, male cells were still evaluation using DNA polymorphisms. Blood 1987; 70:
detectable at the end of the first year and no longer detectable in the separ-1692-1695.
ated fractions of PB cells collected 5 years later in patient No. 1 trans-
